SNBL to Acquire Satsuma Pharmaceuticals

Provided By Globe Newswire

Last update: Apr 17, 2023

Transaction delivers immediate value and liquidity to Satsuma stockholders

SNBL to acquire all outstanding shares of Satsuma for upfront cash consideration of $0.91 per share